Malaysia Defibrillator Market to be dominated by Implantable Cardioverter Defibrillators (ICD) through 2028
The upcoming trend of wearable cardioverter defibrillators are expected
to drive the growth of the Malaysia defibrillator market during the forecast
period.
According to TechSci Research report, “Malaysia Defibrillator Market
–By Region, Competition, Opportunities, and Forecast, 2018-2028”, the
Malaysia defibrillator market is anticipated to grow at an impressive rate
during the forecast period. This can be ascribed to the growing emphasis
on training and education. Efforts to increase awareness of defibrillators and
their importance in saving lives will continue, with initiatives aimed at
training healthcare professionals and general public in the use of
defibrillators and basic life support (BLS). These efforts will help to improve
response times during cardiac emergencies and reduce the risk of complications
and mortality. Additionally, there is a growing emphasis on patient-centric
care. Defibrillators are increasingly designed with patient comfort and
convenience in mind, with features such as smaller sizes, longer battery life,
and wireless connectivity. These features will enable patients to receive
timely treatment in the comfort of their homes, reducing the risk of
complications and improving the quality of life.
The defibrillator market in Malaysia has seen a significant growth over
the last few years, but it is not without its challenges. One of the major
challenges faced by the Malaysia defibrillators market is the high cost of
defibrillators and their maintenance. Defibrillators are relatively expensive
medical devices, making it difficult for smaller healthcare facilities and
public areas to afford them. Additionally, the cost of maintenance, such as
battery replacement and regular checks, can be a burden for healthcare
providers and institutions. Regulatory challenges also pose a significant
barrier to the Malaysia defibrillators market. The government's regulatory
framework is complex, and obtaining necessary approvals for new products can be
time-consuming and expensive. This can deter new players from entering the
market, limiting competition and innovation. The Malaysia defibrillators market
also faces competition from other emergency medical devices, such as automated
chest compressions devices and intravenous medications, which can also be used
to treat cardiac arrest. These devices may be preferred over defibrillators in
certain situations, which, in turn, may limit the growth of the market during
the forecast period.
The Malaysia defibrillator market can be segmented by product, end-use,
and by region. Based on product, the Malaysia defibrillator market can be
divided into implantable cardioverter defibrillators (ICD) and external
defibrillators. The implantable cardioverter defibrillators (ICD) segment is
expected to dominate the market during the forecast period because ICDs can
help improve the quality of life for patients with heart failure or other heart
conditions. Patients who have received an ICD can participate in physical
activities and exercise with confidence, knowing that the device will provide
immediate treatment if needed. Also, ICDs are customizable to each patient’s
individual needs. The device can be programmed to deliver different types of
therapy, depending on the patient’s heart rhythm and condition. This means that
the device can provide the appropriate treatment when needed, without causing
unnecessary shocks or discomfort.
Based on end-use, the Malaysia defibrillator market can be further
divided into hospital, pre-hospital, public access market, alternate care
market, and home healthcare. The hospital segment dominated the market in 2022
and is expected to maintain its dominance during the forecast period. This can
be attributed to the fact that hospitals have advanced monitoring capabilities,
such as telemetry and electrocardiogram (ECG) machines, which can help detect
cardiac arrhythmias at an early stage. This allows for timely intervention and
treatment with a defibrillator, if needed.
Major companies operating in the Malaysia defibrillator market are:
- Philips Healthcare
- ZOLL Medical Malaysia Sdn Bhd
- MINDRAY MEDICAL (M) SDN. BHD.
- Medtronic Malaysia Sdn Bhd
- Schiller Asia Pacific Sdn. Bhd.
- Defibtech, LLC
Customers can also request for 10% free customization
on this report.
“The defibrillator market in Malaysia is poised for growth in the coming
years due to the increasing adoption of advanced technology. Innovations such
as wearable defibrillators, which can be worn by patients at risk of cardiac
arrest, and defibrillators equipped with artificial intelligence (AI)
capabilities, which can provide real-time feedback and analysis, are set to
revolutionize the market. These advanced technologies will enable faster and
more efficient treatment, improving the chances of survival for those in need.
In addition, the Malaysia defibrillators market is set to benefit from
increased investment in healthcare infrastructure and technological innovation.
The Malaysian government has allocated significant funding for healthcare
initiatives, including the installation of defibrillators in schools and public
places. This investment is expected to drive the growth of the market and
enable the development of new and innovative products and services,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Malaysia Defibrillator MarketBy Product (Implantable Cardioverter
Defibrillators (ICD) and External Defibrillators), By End-use (Hospital,
Pre-Hospital, Public Access Market, Alternate Care Market, and Home
Healthcare), and By Region, Competition, Forecast & Opportunities,
2018-2028”, has evaluated the future growth potential of the Malaysia defibrillator
market and provides statistics & information on market size, structure, and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the Malaysia defibrillator
market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656